Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 67
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Mol Cell Biochem ; 477(1): 39-51, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34529223

ABSTRACT

Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, responsible for the synthesis of the CFTR protein, a chloride channel. The gene has approximately 2000 known mutations and all of them affect in some degree the protein function, which makes the pathophysiological manifestations to be multisystemic, mainly affecting the respiratory, gastrointestinal, endocrine, and reproductive tracts. Currently, the treatment of the disease is restricted to controlling symptoms and, more recently, a group of drugs that act directly on the defective protein, known as CFTR modulators, was developed. However, their high cost and difficult access mean that their use is still very restricted. It is important to search for safe and low-cost alternative therapies for CF and, in this context, natural compounds and, mainly, caffeic acid phenethyl ester (CAPE) appear as promising strategies to assist in the treatment of the disease. CAPE is a compound derived from propolis extracts that has antioxidant and anti-inflammatory activities, covering important aspects of the pathophysiology of CF, which points to the possible benefit of its use in the disease treatment. To date, no studies have effectively tested CAPE for CF and, therefore, we intend with this review to elucidate the role of inflammation and oxidative stress for tissue damage seen in CF, associating them with CAPE actions and its pharmacologically active derivatives. In this way, we offer a theoretical basis for conducting preclinical and clinical studies relating the use of this molecule to CF.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Caffeic Acids/therapeutic use , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Cystic Fibrosis/drug therapy , Oxidative Stress/drug effects , Phenylethyl Alcohol/analogs & derivatives , Cystic Fibrosis/genetics , Cystic Fibrosis/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Humans , Inflammation , Mutation , Phenylethyl Alcohol/therapeutic use
2.
Food Funct ; 12(9): 3787-3798, 2021 May 11.
Article in English | MEDLINE | ID: mdl-33977997

ABSTRACT

Liver ischemia-reperfusion injury (IRI) is a phenomenon inherent to hepatic surgery that severely compromises the organ functionality, whose underlying mechanisms involve cellular and molecular interrelated processes leading to the development of an excessive inflammatory response. Liver resident cells and those recruited in response to injury generate pro-inflammatory signals such as reactive oxygen species, cytokines, chemokines, proteases and lipid mediators that contribute to hepatocellular necrosis and apoptosis. Besides, dying hepatocytes release damage-associated molecular patterns that actívate inflammasomes to further stimulate inflammatory responses leading to massive cell death. Since liver IRI is a complication of hepatic surgery in man, extensive preclinical studies have assessed potential protective strategies, including the supplementation with natural compounds, with the objective to downregulate nuclear factor-κB functioning, the main effector of inflammatory responses. This can be accomplished by either the activation of peroxisome proliferator-activated receptor-α, G protein-coupled receptor 120 or antioxidant signaling pathways, the synthesis of specific pro-resolving mediators, downregulation of Toll-like receptor 4 activity or additional contributory mechanisms that are beginning to be understood. The latter aspect is a crucial issue to be accomplished in preclinical studies, in order to establish adequate conditions for the supplementation with natural products before major liver surgeries in man involving warm IR, such as hepatic trauma or resection of large intrahepatic tumors.


Subject(s)
Biological Products/therapeutic use , Fatty Acids, Unsaturated/therapeutic use , Liver/blood supply , Phenylethyl Alcohol/analogs & derivatives , Reperfusion Injury/prevention & control , Reperfusion Injury/therapy , Vitamins/therapeutic use , Animals , Ascorbic Acid/therapeutic use , Humans , Liver/physiopathology , Phenylethyl Alcohol/therapeutic use , Reperfusion Injury/physiopathology , Vitamin E/therapeutic use
3.
Molecules ; 26(8)2021 Apr 12.
Article in English | MEDLINE | ID: mdl-33921289

ABSTRACT

The recent coronavirus disease 2019 (COVID-19) pandemic is a global threat for healthcare management and the economic system, and effective treatments against the pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus responsible for this disease have not yet progressed beyond the developmental phases. As drug refinement and vaccine progression require enormously broad investments of time, alternative strategies are urgently needed. In this study, we examined phytochemicals extracted from Avicennia officinalis and evaluated their potential effects against the main protease of SARS-CoV-2. The antioxidant activities of A. officinalis leaf and fruit extracts at 150 µg/mL were 95.97% and 92.48%, respectively. Furthermore, both extracts displayed low cytotoxicity levels against Artemia salina. The gas chromatography-mass spectroscopy analysis confirmed the identifies of 75 phytochemicals from both extracts, and four potent compounds, triacontane, hexacosane, methyl linoleate, and methyl palminoleate, had binding free energy values of -6.75, -6.7, -6.3, and -6.3 Kcal/mol, respectively, in complexes with the SARS-CoV-2 main protease. The active residues Cys145, Met165, Glu166, Gln189, and Arg188 in the main protease formed non-bonded interactions with the screened compounds. The root-mean-square difference (RMSD), root-mean-square fluctuations (RMSF), radius of gyration (Rg), solvent-accessible surface area (SASA), and hydrogen bond data from a molecular dynamics simulation study confirmed the docked complexes' binding rigidity in the atomistic simulated environment. However, this study's findings require in vitro and in vivo validation to ensure the possible inhibitory effects and pharmacological efficacy of the identified compounds.


Subject(s)
Avicennia/chemistry , COVID-19 Drug Treatment , Phytochemicals/therapeutic use , SARS-CoV-2/metabolism , Antioxidants/chemistry , Antioxidants/metabolism , Antioxidants/therapeutic use , Avicennia/metabolism , Binding Sites , COVID-19/pathology , COVID-19/virology , Fruit/chemistry , Fruit/metabolism , Humans , Molecular Docking Simulation , Molecular Dynamics Simulation , Phenylethyl Alcohol/chemistry , Phenylethyl Alcohol/metabolism , Phenylethyl Alcohol/therapeutic use , Phenylpropionates/chemistry , Phenylpropionates/metabolism , Phenylpropionates/therapeutic use , Phytochemicals/chemistry , Phytochemicals/metabolism , Plant Leaves/chemistry , Plant Leaves/metabolism , SARS-CoV-2/isolation & purification , Viral Matrix Proteins/chemistry , Viral Matrix Proteins/metabolism
4.
Biomolecules ; 11(2)2021 01 28.
Article in English | MEDLINE | ID: mdl-33525407

ABSTRACT

Propolis, a product of the honey bee, has been used in traditional medicine for many years. A hydrophobic bioactive polyphenolic ester, caffeic acid phenethyl ester (CAPE), is one of the most extensively investigated active components of propolis. Several studies have indicated that CAPE has a broad spectrum of pharmacological activities as anti-oxidant, anti-inflammatory, anti-viral, anti-fungal, anti-proliferative, and anti-neoplastic properties. This review largely describes CAPE neuroprotective effects in many different conditions and summarizes its molecular mechanisms of action. CAPE was found to have a neuroprotective effect on different neurodegenerative disorders. At the basis of these effects, CAPE has the ability to protect neurons from several underlying causes of various human neurologic diseases, such as oxidative stress, apoptosis dysregulation, and brain inflammation. CAPE can also protect the nervous system from some diseases which negatively affect it, such as diabetes, septic shock, and hepatic encephalopathy, while numerous studies have demonstrated the neuroprotective effects of CAPE against adverse reactions induced by different neurotoxic substances. The potential role of CAPE in protecting the central nervous system (CNS) from secondary injury following various CNS ischemic conditions and CAPE anti-cancer activity in CNS is also reviewed. The structure-activity relationship of CAPE synthetic derivatives is discussed as well.


Subject(s)
Caffeic Acids/therapeutic use , Phenylethyl Alcohol/analogs & derivatives , Propolis/therapeutic use , Alzheimer Disease/drug therapy , Animals , Anti-Inflammatory Agents/chemistry , Antifungal Agents/chemistry , Antioxidants/chemistry , Antiviral Agents/chemistry , Apoptosis , Brain/drug effects , Caffeic Acids/chemistry , Humans , Inflammation , Ischemia/drug therapy , Neurodegenerative Diseases/drug therapy , Parkinson Disease/drug therapy , Phenylethyl Alcohol/chemistry , Phenylethyl Alcohol/therapeutic use , Propolis/chemistry , Psychotic Disorders/drug therapy , Seizures/drug therapy
5.
Hum Exp Toxicol ; 40(2): 342-354, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32840384

ABSTRACT

Hydroxytyrosol (HT) is among the main bioactive ingredients isolated from olive tree with a variety of biological and pharmacological activities. In the current study, the antioxidative and anti-inflammatory activities of HT were distinguished in the splenic tissue following lipopolysaccharide (LPS)-mediated septic response. Thirty-five Swiss mice were divided into five groups (n = 7): control, HT (40 mg/kg), LPS (10 mg/kg), HT 20 mg+LPS and HT 40 mg+LPS. HT was administered for 10 days, while a single LPS dose was applied. The obtained findings demonstrate that HT administration enhanced the survival rate and decreased lactate dehydrogenase level in LPS-challenged mice. Treatment with HT inhibited the incidence of oxidative damage in splenic tissue through decreasing lipoperoxidation and increasing antioxidant molecules, namely glutathione, superoxide dismutase and catalase. HT also decreased total leukocytes count, C-reactive protein, monocyte chemoattractant protein-1, and myeloperoxidase levels. Additionally, HT suppressed the production levels of tumor necrosis factor-α, interleukin-1ß, and interleukin-6. Moreover, mRNA expression of inducible nitric oxide synthase and nitric oxide production were increased after HT administration. Furthermore, HT supplementation resulted in a downregulation of p38 mitogen-activated protein kinase, inhibited the activation of the nuclear factor kappa-B from the nucleus to the cytoplasm, and attenuated infiltration of activated immune cells and tissue injury following LPS injection. Collectively, these findings demonstrate the antioxidative and anti-inflammatory properties of HT against LPS-mediated inflammation and sepsis. Therefore, HT could be applied as an alternative anti-inflammatory agent to minimize or prevent the development of systemic inflammatory response associated with septic shock.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Phenylethyl Alcohol/analogs & derivatives , Sepsis/drug therapy , Animals , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , C-Reactive Protein/analysis , Catalase/metabolism , Cytokines/genetics , Glutathione/metabolism , Leukocyte Count , Lipopolysaccharides , Male , Mice , NF-kappa B/metabolism , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/genetics , Oxidative Stress/drug effects , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Sepsis/genetics , Sepsis/immunology , Sepsis/pathology , Spleen/drug effects , Spleen/immunology , Spleen/metabolism , Spleen/pathology , Superoxide Dismutase/metabolism , p38 Mitogen-Activated Protein Kinases/genetics
6.
Int J Mol Sci ; 21(11)2020 May 31.
Article in English | MEDLINE | ID: mdl-32486445

ABSTRACT

: Many synthetic drugs and monoclonal antibodies are currently in use to treat Inflammatory Bowel Disease (IBD). However, they all are implicated in causing severe side effects and long-term use results in many complications. Numerous in vitro and in vivo experiments demonstrate that phytochemicals and natural macromolecules from plants and animals reduce IBD-related complications with encouraging results. Additionally, many of them modify enzymatic activity, alleviate oxidative stress, and downregulate pro-inflammatory transcriptional factors and cytokine secretion. Translational significance of natural nanomedicine and strategies to investigate future natural product-based nanomedicine is discussed. Our focus in this review is to summarize the use of phytochemicals and macromolecules encapsulated in nanoparticles for the treatment of IBD and IBD-associated colorectal cancer.


Subject(s)
Biological Products/therapeutic use , Inflammatory Bowel Diseases/therapy , Nanomedicine , Animals , Benzoquinones/therapeutic use , Biomimetics , Caffeic Acids/therapeutic use , Curcumin/therapeutic use , Cytokines/metabolism , Exosomes/chemistry , Zingiber officinale/metabolism , Humans , Inflammation/drug therapy , Insecta , Macromolecular Substances/therapeutic use , Oxidative Stress , Phenylethyl Alcohol/analogs & derivatives , Phenylethyl Alcohol/therapeutic use , Phytochemicals/therapeutic use , Plant Extracts/therapeutic use , Polysaccharides/therapeutic use , Quercetin/therapeutic use , Resveratrol/therapeutic use , Stilbenes/therapeutic use , Transcription Factors/metabolism , Translational Research, Biomedical , Vasoactive Intestinal Peptide/therapeutic use
7.
Am J Hypertens ; 33(7): 652-659, 2020 07 18.
Article in English | MEDLINE | ID: mdl-32179885

ABSTRACT

BACKGROUND: Myoinositol (M) and D-chiro-inositol (D) are insulin sensitizer compounds, while fucoxanthin (F) and hydroxytyrosol (H) are antioxidant substances. We aim to investigate if the combination of these compounds, will improve the vascular responses in pregnant mouse models of hypertension: a genetic model, transgenic heterozygous mice lacking endothelial nitric oxide synthase gene (eNOS-/+); and environmental, wild-type (WT) mice. Those mouse models will allow a better understanding of the genetic/environmental contribution to hypertension in pregnancy. METHODS: eNOS-/+ and WT female were fed high fat diet for 4 weeks, then at 7-8 weeks of age were mated with WT male. On gestational day (GD) 1, they were randomly allocated to receive MDFH treatment or water as control: eNOS-/+ MDFH (n = 13), eNOS-/+ (n = 13), WT-MDFH (n = 14), and WT (n = 20). Systolic blood pressure (SBP) was obtained at GD 18, then dams were sacrificed; fetuses and placentas collected, and 2 mm segments of carotid arteries isolated for vascular responses using the wire-myograph system. Responses to phenylephrine (PE), with/without the NOS inhibitor (N-nitro-l-arginine methyl ester (l-NAME)), and to acetylcholine (Ach) and sodium nitroprussiate (SNP) were performed. RESULTS: SBP decreased in eNOS-/+ and WT dams after MDFH supplementation. In eNOS-/+, MDFH lower the contractile response to PE and l-NAME and improved Ach vasorelaxation. In WT dams, MDFH treatment did not affect PE response; MDFH treatment lowered the vascular PE response after incubation with l-NAME. No differences were seen in SNP relaxation in both models. CONCLUSIONS: MDFH decreased SBP in both genetically and environmentally hypertensive dams and improved vascular responses mostly in the eNOS-/+ dams.


Subject(s)
Antioxidants/therapeutic use , Hypertension/drug therapy , Inositol/therapeutic use , Phenylethyl Alcohol/analogs & derivatives , Xanthophylls/therapeutic use , Animals , Dietary Supplements , Disease Models, Animal , Drug Evaluation, Preclinical , Drug Therapy, Combination , Female , Mice , Mice, Knockout , Phenylethyl Alcohol/therapeutic use , Pregnancy , Random Allocation
8.
J Biotechnol ; 308: 82-86, 2020 Jan 20.
Article in English | MEDLINE | ID: mdl-31794783

ABSTRACT

Lymphedema is a chronic accumulation of interstitial fluid due to inefficient lymph drainage. Major causes of lymphedema are malformations of lymphatic vessels, trauma, toxic damage and surgery. The swelling typically affects the limbs. Lymphedema may be primary, caused by genetic mutations and relatively rare, or secondary (acquired), due to external causes such as infections or surgery. Fluid accumulation induces pathological changes: activation of the inflammatory cascade, immune cell infiltration, tissue fibrosis, adipose accumulation. We focused on the inflammatory phenotype mediated by leukotriene B4, a lipid mediator of the inflammatory pathway, and the potential therapeutic effect of hydroxytyrosol. We conducted an electronic search in PubMed using "lymphedema", "lymphedema pathway", "hydroxytyrosol" as keywords. We found that lymphedema deregulates at least six molecular pathways and that hydroxytyrosol, a compound with antioxidant activity, can improve endothelial dysfunction, hemostatic and lipid profiles, and decrease oxidative stress and inflammation through inhibition of leukotriene B4 activity. This review is the first to highlight the possibility of using hydroxytyrosol to treat the secondary effects of lymphedema, especially inflammation. The possible effects of hydroxytyrosol on lymphedema should be tested in vitro and in vivo to find the best way to treat patients with lymphedema in order to improve their health status.


Subject(s)
Antioxidants/pharmacology , Lymphedema/metabolism , Metabolic Networks and Pathways/drug effects , Phenylethyl Alcohol/analogs & derivatives , Animals , Antioxidants/therapeutic use , Gene Expression Regulation/drug effects , Hemostasis , Humans , Leukotriene B4/metabolism , Lymphedema/drug therapy , Lymphedema/etiology , Olea/chemistry , Oxidative Stress/drug effects , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Plant Extracts/pharmacology , Plant Extracts/therapeutic use
9.
Andrologia ; 52(2): e13499, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31828839

ABSTRACT

Aluminium is a ubiquitous element that occurs naturally in the soil making human exposure to it is unavoidable. Tyrosol is present in olive oil and is known to have antioxidant effects. Therefore, the present study explores the toxic effects of aluminium chloride (AlCl3 ) and evaluates the possible protection by tyrosol in male rats. Testicular injury was induced by the administration of AlCl3 (34 mg kg-1  day-1 ). Rats were treated with either tyrosol (20 mg kg-1 day-1 ) or AlCl3 (34 mg kg-1 day-1 ). The experiment lasted for 10 weeks. Biochemical, histopathological and protein expression profiles were determined to decipher the role of tyrosol in protecting the cellular damage. Further, histomorphometric analyses of testes showed deranged architecture along with other noted abnormalities. AlCl3 group rats' testes showed decreased GSH levels, CAT activities, Nrf-2, HO-1, bcl-2 expressions and sperm motility whereas increased caspase-3 expressions, MDA levels, abnormal and dead/live sperm ratio. However, tyrosol treatment attenuated these changes. The present results demonstrate the beneficial role of tyrosol treatment in AlCl3 induced testicular toxicity alterations of rat.


Subject(s)
Aluminum Chloride/toxicity , Antioxidants/therapeutic use , Infertility, Male/prevention & control , Phenylethyl Alcohol/analogs & derivatives , Testis/drug effects , Animals , Antioxidants/pharmacology , Drug Evaluation, Preclinical , Heme Oxygenase (Decyclizing)/metabolism , Infertility, Male/chemically induced , Infertility, Male/pathology , Male , NF-E2-Related Factor 2/metabolism , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Rats, Wistar , Testis/metabolism
10.
Medicina (Kaunas) ; 55(5)2019 May 09.
Article in English | MEDLINE | ID: mdl-31075882

ABSTRACT

Cardiovascular diseases (CVDs) account for the majority of deaths worldwide. Radiation-induced heart diseases (RIHD) is one of the side effects following exposure to ionizing radiation (IR). Exposure could be from various forms such as diagnostic imaging, radiotherapy for cancer treatment, as well as nuclear disasters and nuclear accidents. RIHD is mostly observed after radiotherapy for thoracic malignancies, especially left breast cancer. RIHD may affect the supply of blood to heart muscles, leading to an increase in the risk of heart attacks to irradiated persons. Due to its dose-limiting consequence, RIHD has a negative effect on the therapeutic efficacy of radiotherapy. Several methods have been proposed for protection against RIHD. In this paper, we review the use of natural products, which have shown promising results for protection against RIHD.


Subject(s)
Biological Products/therapeutic use , Heart Diseases/etiology , Protective Factors , Radiation Injuries/complications , Caffeic Acids/pharmacology , Caffeic Acids/therapeutic use , Curcumin/pharmacology , Curcumin/therapeutic use , Drug Combinations , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Guaiacol/analogs & derivatives , Guaiacol/pharmacology , Guaiacol/therapeutic use , Heart Diseases/physiopathology , Hesperidin/pharmacology , Hesperidin/therapeutic use , Humans , Melatonin/pharmacology , Melatonin/therapeutic use , Phenylethyl Alcohol/analogs & derivatives , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Radiation Injuries/physiopathology , Selenium/pharmacology , Selenium/therapeutic use , Vitis
11.
Mol Immunol ; 108: 81-88, 2019 04.
Article in English | MEDLINE | ID: mdl-30784766

ABSTRACT

High altitude cerebral edema (HACE), whose development process is associated with oxidative stress and inflammatory response, is a life-threatening condition caused by rapid ascent speed to high altitudes. Phenylethanoid glycosides (PhGCs) are primary active constituents isolated from Phlomis younghusbandii Mukerjee that reportedly exhibit potent anti-oxidant and anti-inflammatory activities. The present study aims to investigate the protective effect of phenylethanoid glycosides (PhGCs) from P. younghusbandii in acute hypobaric hypoxia (AHH) - stimulated HACE rats and its underlying mechanisms. The expression of pro-inflammatory cytokine levels (IL-1ß, TNF-α, and IL-6) was detected by RT-PCR and ELISA at mRNA and protein levels in brain tissues. Western blotting was carried out to measure the major protein levels (IL-1ß, TNF-α, and NF-κB) in brain tissues. The oxidative stress biomarkers (MDA, SOD, and GSH) were evaluated using kits. Results demonstrate that PhGCs significantly improved pathological changes in brain tissues, reduced the brain's water content, and attenuated the production and mRNA expression of pro-inflammatory cytokines. Furthermore, the increased oxidative stress and the decrease in anti-oxidant stress system under the AHH condition were also abrogated reversely through PhGCs treatment by elevating the levels of SOD and GSH and suppressing the accumulation of MDA. Simultaneously, there was also a significant reduction in NF-κB, IL-1ß, and TNF-α protein expression levels in brain tissues, suggesting that blocking the NF-κB signaling pathway activation prevented the production of pro-inflammatory cytokines. Taken together, these findings indicate that PhGCs may afford a protectively intervene in HACE through the suppression of oxidative stress and inflammatory response via the inhibition of the NF-κB signaling pathway, indicating that PhGCs are promising agents for the treatment of acute HACE.


Subject(s)
Altitude Sickness/drug therapy , Brain Edema/drug therapy , Brain Edema/etiology , Glycosides/therapeutic use , Hypoxia/complications , Phenylethyl Alcohol/therapeutic use , Phlomis/chemistry , Acute Disease , Animals , Cytokines/genetics , Cytokines/metabolism , Glycosides/pharmacology , Inflammation Mediators/metabolism , Male , NF-kappa B/metabolism , Oxidative Stress/drug effects , Phenylethyl Alcohol/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats, Wistar , Signal Transduction/drug effects , Water
12.
Int J Mol Sci ; 19(7)2018 Jul 12.
Article in English | MEDLINE | ID: mdl-30002281

ABSTRACT

Lifestyle is the primary prevention of diabetes, especially type-2 diabetes (T2D). Nutritional intake of olive oil (OO), the key Mediterranean diet component has been associated with the prevention and management of many chronic diseases including T2D. Several OO bioactive compounds such as monounsaturated fatty acids, and key biophenols including hydroxytyrosol and oleuropein, have been associated with preventing inflammation and cytokine-induced oxidative damage, glucose lowering, reducing carbohydrate absorption, and increasing insulin sensitivity and related gene expression. However, research into the interaction of OO nutraceuticals with lifestyle components, especially physical activity, is lacking. Promising postprandial effects have been reported when OO or other similar monounsaturated fatty acids were the main dietary fat compared with other diets. Animal studies have shown a potential anabolic effect of oleuropein. Such effects could be further potentiated via exercise, especially strength training, which is an essential exercise prescription for individuals with T2D. There is also an evidence from in vitro, animal, and limited human studies for a dual preventative role of OO biophenols in diabetes and cancer, especially that they share similar risk factors. Putative antioxidative and anti-inflammatory mechanisms and associated gene expressions resulting from OO biophenols have produced paradoxical results, making suggested inferences from dual prevention T2D and cancer outcomes difficult. Well-designed human interventions and clinical trials are needed to decipher such a potential dual anticancer and antidiabetic effects of OO nutraceuticals. Exercise combined with OO consumption, individually or as part of a healthy diet is likely to induce reciprocal action for T2D prevention outcomes.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/prevention & control , Dietary Supplements , Iridoids/therapeutic use , Life Style , Olive Oil/therapeutic use , Phenylethyl Alcohol/analogs & derivatives , Diabetes Mellitus, Type 2/pathology , Dietary Fats/therapeutic use , Humans , Iridoid Glucosides , Phenylethyl Alcohol/therapeutic use
13.
Integr Cancer Ther ; 17(3): 867-873, 2018 09.
Article in English | MEDLINE | ID: mdl-29390900

ABSTRACT

Besides honey, honeybees make a sticky substance (called propolis/bee glue) by mixing saliva with poplar tree resin and other botanical sources. It is known to be rich in bioactivities of which the anticancer activity is most studied. Caffeic acid phenethyl ester (CAPE) is a key anticancer component in New Zealand propolis. We have earlier investigated the molecular mechanism of anticancer activity in CAPE and reported that it activates DNA damage signaling in cancer cells. CAPE-induced growth arrest of cells was mediated by downregulation of mortalin and activation of p53 tumor suppressor protein. When antitumor and antimetastasis activities of CAPE were examined in vitro and in vivo, we failed to find significant activities, which was contrary to our expectations. On careful examination, it was revealed that CAPE is unstable and rather gets easily degraded into caffeic acid by secreted esterases. Interestingly, when CAPE was complexed with γ-cyclodextrin (γCD) the activities were significantly enhanced. In the present study, we report that the CAPE-γCD complex with higher cytotoxicity to a wide range of cancer cells is stable in acidic milieu and therefore recommended as an anticancer amalgam. We also report a method for preparation of stable and less-pungent powder of propolis that could be conveniently used for health and therapeutic benefits.


Subject(s)
Antineoplastic Agents/pharmacology , Caffeic Acids/pharmacology , Phenylethyl Alcohol/analogs & derivatives , Propolis/pharmacology , gamma-Cyclodextrins/pharmacology , A549 Cells , Animals , Antineoplastic Agents/therapeutic use , Apitherapy , Caffeic Acids/chemistry , Caffeic Acids/therapeutic use , Drug Combinations , Female , HeLa Cells , Humans , MCF-7 Cells , Mice , Mice, Inbred BALB C , Mice, Nude , Phenylethyl Alcohol/chemistry , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Propolis/therapeutic use , Tumor Cells, Cultured , Xenograft Model Antitumor Assays , gamma-Cyclodextrins/chemistry , gamma-Cyclodextrins/therapeutic use
14.
Food Res Int ; 105: 654-667, 2018 03.
Article in English | MEDLINE | ID: mdl-29433260

ABSTRACT

Many beneficial properties have been attributed to the Mediterranean diet. Over the years, researchers have attempted to learn which foods and which food components are responsible for good health. One of these components is hydroxytyrosol, an important phenolic compound present in olive oil. Hydroxytyrosol is a molecule of high interest to the pharmaceutical industry due to its anti-inflammatory and antimicrobial qualities its role against cardiovascular diseases and metabolic syndrome and for its neuroprotection, antitumour, and chemo modulation effects. The interest in this molecule has led to wide research on its biological activities, its beneficial effects in humans and how to synthetize new molecules from hydroxytyrosol. This review describes the vast range of information about hydroxytyrosol, focusing on its involvement in biological mechanisms and modulation effects on different pathologies. This review also serves to highlight the role of hydroxytyrosol as a nutraceutical and as a potential therapeutic agent.


Subject(s)
Anti-Infective Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Antioxidants/therapeutic use , Diet, Healthy , Diet, Mediterranean , Dietary Supplements , Olive Oil/chemistry , Phenylethyl Alcohol/analogs & derivatives , Animals , Anti-Infective Agents/adverse effects , Anti-Infective Agents/isolation & purification , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents/isolation & purification , Antineoplastic Agents/adverse effects , Antineoplastic Agents/isolation & purification , Antioxidants/adverse effects , Antioxidants/isolation & purification , Dietary Supplements/adverse effects , Humans , Phenylethyl Alcohol/adverse effects , Phenylethyl Alcohol/isolation & purification , Phenylethyl Alcohol/therapeutic use
15.
Article in English | MEDLINE | ID: mdl-29141573

ABSTRACT

BACKGROUND AND OBJECTIVE: The liver is an organ susceptible to a multitude of injuries that causes liver damage, like steatosis, non-alcoholic steatohepatitis, cirrhosis, hepatocellular carcinoma, and ischemia-reperfusion injury. Extra virgin olive oil (EVOO), presents several protective effects on the liver, reducing hepatic steatosis, hepatocyte ballooning, fibrogenesis, preventing lipid peroxidation, among other effects. Due to its high levels of monounsaturated fatty acids, mainly oleic acid and phenolic compounds, such as hydroxytyrosol and oleuropein, EVOO is able to participate in the activation of different signaling pathways in the hepatocytes involved in the prevention of inflammation, oxidative stress, endoplasmic reticulum stress, mitochondrial dysfunction, and insulin resistance, allowing the prevention or resolution of liver damage. The aim of this work is to offer an update of the molecular effects of EVOO in the liver and its protective properties to prevent the establishment of liver damage through the regulation of different cell-signaling pathways. METHODS: Searches that considered the effects of EVOO in in vivo and in vitro models, whith emphasis in the molecular mechanism of liver tissue damage and prevention and/or treatment of steatosis, steatohepatitis, cirrhosis, hepatocellular carcinoma, and ischemia-reperfusion injury. CONCLUSION: The most relevant molecular effects of EVOO involved in the prevention or resolution of liver damage are: (i) Activation of the nuclear transcription factor erythroid-derived 2-like 2 (Nfr2), inducing the cellular antioxidant response; (ii) Inactivation of the nuclear transcription factor-κB (NF- κB), preventing the cellular inflammatory response; and (iii) Inhibition of the PERK pathway, preventing endoplasmic reticulum stress, autophagy, and lipogenic response.


Subject(s)
Dietary Fats, Unsaturated/therapeutic use , Food Quality , Functional Food , Liver/metabolism , Non-alcoholic Fatty Liver Disease/prevention & control , Olive Oil/therapeutic use , Animals , Anti-Inflammatory Agents, Non-Steroidal/analysis , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antioxidants/analysis , Antioxidants/therapeutic use , Autophagy , Dietary Fats, Unsaturated/analysis , Dietary Fats, Unsaturated/standards , Dietary Supplements , Endoplasmic Reticulum Stress , Functional Food/analysis , Humans , Lipogenesis , Liver/enzymology , Liver/immunology , Non-alcoholic Fatty Liver Disease/diet therapy , Non-alcoholic Fatty Liver Disease/immunology , Non-alcoholic Fatty Liver Disease/metabolism , Olive Oil/chemistry , Olive Oil/standards , Phenylethyl Alcohol/analogs & derivatives , Phenylethyl Alcohol/analysis , Phenylethyl Alcohol/therapeutic use , Signal Transduction
16.
Lipids Health Dis ; 16(1): 64, 2017 Apr 11.
Article in English | MEDLINE | ID: mdl-28395666

ABSTRACT

BACKGROUND: Eicosapentaenoic acid (EPA, C20:5n-3), docosahexaenoic acid (DHA, C22:6n-3) and arachidonic acid (AA, C20:4n-6) are long-chain polyunsaturated fatty acids (LCPUFAs) with relevant roles in the organism. EPA and DHA are synthesized from the precursor alpha-linolenic acid (ALA, C18:3n-3), whereas AA is produced from linoleic acid (LA, C18:2n-6) through the action of Δ5 and Δ6-desaturases. High-fat diet (HFD) decreases the activity of both desaturases and LCPUFA accretion in liver and other tissues. Hydroxytyrosol (HT), a natural antioxidant, has an important cytoprotective effects in different cells and tissues. METHODS: Male mice C57BL/6 J were fed a control diet (CD) (10% fat, 20% protein, 70% carbohydrates) or a HFD (60% fat, 20% protein, 20% carbohydrates) for 12 weeks. Animals were daily supplemented with saline (CD) or 5 mg HT (HFD), and blood and the studied tissues were analyzed after the HT intervention. Parameters studied included liver histology (optical microscopy), activity of hepatic desaturases 5 and 6 (gas-liquid chromatography of methyl esters derivatives) and antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase, and glutathione reductase by spectrophotometry), oxidative stress indicators (glutathione, thiobarbituric acid reactants, and the antioxidant capacity of plasma), gene expression assays for sterol regulatory element-binding protein 1c (SREBP-1c) (qPCR and ELISA), and LCPUFA profiles in liver, erythrocyte, brain, heart, and testicle (gas-liquid chromatography). RESULTS: HFD led to insulin resistance and liver steatosis associated with SREBP-1c upregulation, with enhancement in plasma and liver oxidative stress status and diminution in the synthesis and storage of n-6 and n-3 LCPUFAs in the studied tissues, compared to animals given control diet. HT supplementation significantly reduced fat accumulation in liver and plasma as well as tissue metabolic alterations induced by HFD. Furthermore, a normalization of desaturase activities, oxidative stress-related parameters, and tissue n-3 LCPUFA content was observed in HT-treated rats over control animals. CONCLUSIONS: HT supplementation prevents metabolic alterations in desaturase activities, oxidative stress status, and n-3 LCPUFA content in the liver and extrahepatic tissues of mice fed HFD.


Subject(s)
Antioxidants/therapeutic use , Dietary Supplements , Fatty Acid Desaturases/metabolism , Linoleoyl-CoA Desaturase/metabolism , Liver/metabolism , Non-alcoholic Fatty Liver Disease/prevention & control , Phenylethyl Alcohol/analogs & derivatives , Animals , Biomarkers/blood , Biomarkers/metabolism , Delta-5 Fatty Acid Desaturase , Diet, High-Fat/adverse effects , Fatty Acid Desaturases/chemistry , Fatty Acids, Omega-3/agonists , Fatty Acids, Omega-3/metabolism , Fatty Acids, Omega-6/agonists , Fatty Acids, Omega-6/metabolism , Hydroxylation , Insulin Resistance , Linoleoyl-CoA Desaturase/chemistry , Liver/enzymology , Liver/pathology , Male , Mice, Inbred C57BL , Non-alcoholic Fatty Liver Disease/etiology , Non-alcoholic Fatty Liver Disease/metabolism , Non-alcoholic Fatty Liver Disease/pathology , Organ Specificity , Oxidative Stress , Phenylethyl Alcohol/therapeutic use , Random Allocation , Weaning
17.
Curr Drug Targets ; 18(13): 1477-1486, 2017.
Article in English | MEDLINE | ID: mdl-27719659

ABSTRACT

BACKGROUND: The Mediterranean diet includes olive oil as its primary source of fat. This diet is frequently associated to longevity and a lower incidence of chronic diseases due to its biological activities and health effects. Apart from oleic acid, olive oil contains many bioactive components including polyphenols that have been reported to exert antioxidant and anti-inflammatory activities. Polyphenols may almost in part be responsible for the protective effects against cardiovascular diseases associated with olive oil. OBJECTIVE: To review and discuss the available literature on hydroxytyrosol effects as a cardioprotective agent. Moreover, we also discuss the chemistry, nutritional aspects and bioavailability of hydroxytyrosol. RESULTS: Hydroxytyrosol is one of the major phenolic compounds in olive oil and has demonstrated strong radical-scavenging properties. Several studies have been performed in order to look further into the effects of the polyphenol hydroxytyrosol in relation to cardiovascular events and illnesses in animal trials and in vitro. However, no clinical trials have focused on the specific action of hydroxytyrosol and cardiovascular diseases, although some are being undertaken to look at olive oil or olive leaf extract properties. CONCLUSION: Hydroxytyrosol from olive oil exerts antioxidant, anti-inflammatory, anti-platelet aggregation and ati-atherogenic activities in in vitro and animal models. However, its possible therapeutic use in humans requires additional clinical trials.


Subject(s)
Cardiovascular Diseases/prevention & control , Olive Oil/chemistry , Phenylethyl Alcohol/analogs & derivatives , Platelet Aggregation Inhibitors/therapeutic use , Animals , Biological Availability , Humans , Molecular Structure , Oxidative Stress/drug effects , Phenylethyl Alcohol/chemistry , Phenylethyl Alcohol/pharmacokinetics , Phenylethyl Alcohol/therapeutic use , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/pharmacology
18.
Sci Rep ; 6: 33527, 2016 09 19.
Article in English | MEDLINE | ID: mdl-27640363

ABSTRACT

Polyphenols exert a large range of beneficial effects in the prevention of age-related diseases. We sought to determine whether an extract of olive and grape seed standardized according to hydroxytyrosol (HT) and procyanidins (PCy) content, exerts preventive anti-osteoathritic effects. To this aim, we evaluated whether the HT/PCy mix could (i) have in vitro anti-inflammatory and chondroprotective actions, (ii) exert anti-osteoarthritis effects in two post-traumatic animal models and (iii) retain its bioactivity after oral administration. Anti-inflammatory and chondroprotective actions of HT/PCy were tested on primary cultured rabbit chondrocytes stimulated by interleukin-1 beta (IL-1ß). The results showed that HT/PCy exerts anti-inflammatory and chondroprotective actions in vitro. The preventive effect of HT/PCy association was assessed in two animal models of post-traumatic OA in mice and rabbits. Diet supplementation with HT/PCy significantly decreased the severity of post-traumatic osteoarthritis in two complementary mice and rabbit models. The bioavailability and bioactivity was evaluated following gavage with HT/PCy in rabbits. Regular metabolites from HT/PCy extract were found in sera from rabbits following oral intake. Finally, sera from rabbits force-fed with HT/PCy conserved anti-IL-1ß effect, suggesting the bioactivity of this extract. To conclude, HT/PCy extract may be of clinical significance for the preventive treatment of osteoarthritis.


Subject(s)
Grape Seed Extract/administration & dosage , Grape Seed Extract/therapeutic use , Interleukin-1beta/metabolism , Olea/chemistry , Osteoarthritis/drug therapy , Osteoarthritis/prevention & control , Wounds and Injuries/complications , Administration, Oral , Animals , Anterior Cruciate Ligament/drug effects , Anterior Cruciate Ligament/surgery , Biflavonoids/pharmacology , Biflavonoids/therapeutic use , Catechin/pharmacology , Catechin/therapeutic use , Cyclooxygenase 2/metabolism , Diet , Dinoprostone/metabolism , Disease Models, Animal , Female , Grape Seed Extract/pharmacology , Male , Mass Spectrometry , Matrix Metalloproteinase 13/genetics , Matrix Metalloproteinase 13/metabolism , Metabolome , Mice, Inbred C57BL , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/metabolism , Osteoarthritis/blood , Osteoarthritis/etiology , Phenylethyl Alcohol/analogs & derivatives , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Proanthocyanidins/pharmacology , Proanthocyanidins/therapeutic use , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rabbits
19.
J Nutr Biochem ; 37: 94-100, 2016 11.
Article in English | MEDLINE | ID: mdl-27648880

ABSTRACT

The aim of this study was to assess the influence of hydroxytyrosol (HT) on cardiovascular biomarkers and morphometric parameters of the arterial wall in streptozotocin-diabetic rats. Seven groups of rats (N=10 per group) were studied for 2 months: nondiabetic rats (NDR), diabetic rats treated with saline (DR) and DR treated with HT (0.5, 1, 2.5, 5 and 10 mg kg-1 day-1 p.o.). DR had higher platelet aggregation values, higher thromboxane B2, plasma lipid peroxidation, 3-nitrotyrosine, oxidized LDL (oxLDL), myeloperoxidase, vascular cell adhesion molecule 1 (VCAM-1) and interleukin-1ß (IL-1ß) concentrations, and lower aortic 6-keto-prostaglandin F1α and nitric oxide production than NDR. Aortic wall area and smooth muscle cell count were also higher in DR than in NDR. HT significantly reduced both oxidative and nitrosative stress, oxLDL concentration, VCAM-1 and inflammatory mediators, platelet aggregation and thromboxane B2 production. Morphometric values in the aortic wall were reduced to values near those in NDR. In conclusion, HT influenced the major biochemical processes leading to diabetic vasculopathy, and reduced cell proliferation in the vascular wall in this experimental model.


Subject(s)
Antioxidants/therapeutic use , Cardiovascular Diseases/prevention & control , Diabetes Mellitus, Experimental/diet therapy , Diabetic Angiopathies/prevention & control , Diabetic Cardiomyopathies/prevention & control , Dietary Supplements , Phenylethyl Alcohol/analogs & derivatives , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antioxidants/administration & dosage , Aorta, Abdominal , Biomarkers/blood , Biomarkers/metabolism , Cardiovascular Diseases/complications , Cardiovascular Diseases/immunology , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Diabetic Angiopathies/immunology , Diabetic Cardiomyopathies/immunology , Endothelium, Vascular/immunology , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/blood , Inflammation Mediators/metabolism , Lipid Peroxidation , Lipoproteins, LDL/blood , Male , Muscle, Smooth, Vascular/immunology , Muscle, Smooth, Vascular/metabolism , Muscle, Smooth, Vascular/pathology , Oxidative Stress , Phenylethyl Alcohol/administration & dosage , Phenylethyl Alcohol/therapeutic use , Platelet Aggregation , Rats, Wistar , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/blood , Reactive Nitrogen Species/metabolism , Streptozocin
20.
Molecules ; 21(8)2016 Jul 29.
Article in English | MEDLINE | ID: mdl-27483229

ABSTRACT

Phenylethanoid glycosides (PhGs) are widely distributed in traditional Chinese medicines as well as in other medicinal plants, and they were characterized by a phenethyl alcohol (C6-C2) moiety attached to a ß-glucopyranose/ß-allopyranose via a glycosidic bond. The outstanding activity of PhGs in diverse diseases proves their importance in medicinal chemistry research. This review summarizes new findings on PhGs over the past 10 years, concerning the new structures, their bioactivities, including neuroprotective, anti-inflammatory, antioxidant, antibacterial and antivirus, cytotoxic, immunomodulatory, and enzyme inhibitory effects, and pharmacokinetic properties.


Subject(s)
Drugs, Chinese Herbal , Glycosides , Phenylethyl Alcohol , Plants, Medicinal/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/pharmacokinetics , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacokinetics , Anti-Inflammatory Agents/therapeutic use , Antioxidants/chemistry , Antioxidants/isolation & purification , Antioxidants/pharmacokinetics , Antioxidants/therapeutic use , Antiviral Agents/chemistry , Antiviral Agents/isolation & purification , Antiviral Agents/pharmacokinetics , Antiviral Agents/therapeutic use , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacokinetics , Drugs, Chinese Herbal/therapeutic use , Glycosides/chemistry , Glycosides/isolation & purification , Glycosides/pharmacokinetics , Glycosides/therapeutic use , Immunologic Factors/chemistry , Immunologic Factors/isolation & purification , Immunologic Factors/pharmacokinetics , Immunologic Factors/therapeutic use , Neuroprotective Agents/chemistry , Neuroprotective Agents/isolation & purification , Neuroprotective Agents/pharmacokinetics , Neuroprotective Agents/therapeutic use , Phenylethyl Alcohol/chemistry , Phenylethyl Alcohol/isolation & purification , Phenylethyl Alcohol/pharmacokinetics , Phenylethyl Alcohol/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL